|
PCVX Vaxcyte Inc 1649094 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-320,622,000.00 |
| Balance Sheet |
|
Current Assets
|
$1,813,488,000.00 |
|
Assets
|
$3,348,308,000.00 |
|
Current Liabilities
|
$242,082,000.00 |
|
Liabilities
|
$352,294,000.00 |
|
Equity
|
$2,996,014,000.00 |
|
Shares Out
|
144314981.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-280,625,000.00 |
|
Investing Cash Flow
|
$-233,410,000.00 |
| Market Analysis |
Market Cap
|
$8,075,866,336.76 |
|
Price
|
$53.13 |
|
BVPS
|
20.76 |
|
PB
|
2.70 |
|
EPS
|
-2.30 |
|
FCF
|
$-282,732,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:17 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:11 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-24 |
-5.63 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-06 |
-2.30 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-1.22 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
-1.56 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PCVX documents filed with the SEC.
PCVX Filings
Clear
